SBI Holdings, Inc. (8473.T) JPX
Currency In JPY
- General
- Statistics
- Historical Data
- Profile
- Financials
SBI Holdings, Inc.
Sector
Financial Services
Industry
Asset Management
Employees
19097
First IPO Date
January 04, 2001
Key Executives
| Name | Title | Pay | Year Born |
| Yoshitaka Kitao | Chairman, President, CEO & Representative Director | 329M | 1951 |
| Tomoya Asakura | Senior Executive Vice President & Representative Director | 129M | 1966 |
| Masato Takamura | Senior EVice President, Chief Operating Officer, Senior Head of Financial Services Business & Representative Director | 207M | 1969 |
| Yasuo Nishikawa | Executive Officer, Chief Financial Officer & Director | 0 | 1976 |
| Hideyuki Katsuchi | Executive Officer of Accounting & Finance | 0 | N/A |
| Masashi Okuyama | Executive Officer, GM of the Legal & Compliance and Director | 0 | N/A |
| Satoe Kusakabe | MD & Director | 0 | 1970 |
| Motoaki Shiino | GM of Corporate Communication Department & Director | 0 | 1974 |
Description
SBI Holdings, Inc. is a Japanese conglomerate primarily engaged in online financial services and strategic investments, both domestically and internationally. Its operations are structured around three key pillars: Financial Services, Asset Management, and the Biotechnology, Healthcare, and Medical Informatics sectors. The company provides a comprehensive suite of financial products, including online brokerage, investment banking, and internet banking facilities. It offers various insurance solutions such as automobile, health (cancer), property (fire, earthquake), and life coverage, alongside short-term insurance. Further financial offerings encompass foreign exchange (FX) margin trading, online securities, and services related to digital asset exchange and transactions. SBI also manages defined-contribution pension schemes, provides leasing and lending services, and operates a proprietary trading system. Its involvement extends to e-commerce settlement processing, remittance services, and essential back-office support. Beyond traditional banking, SBI is active in private equity and venture capital fund management, offers mergers and acquisitions (M&A) advisory, and runs savings and commercial banking operations. It provides investment advisory and management services, alongside rating information services. The firm also deals with real estate-secured loans and offers rent guarantees for residential properties. In the biotechnology and healthcare domain, SBI conducts research, manufactures, and distributes pharmaceutical products, health supplements, and cosmetics. It develops, produces, sells, and maintains integrated medical information systems. Furthermore, it's involved in the research and development of advanced antibody and nucleic acid drugs targeting cancer and immunological conditions. The company's diverse portfolio includes operating a fund-raising platform, serving as a crypto-asset broker, and developing, manufacturing, and selling crypto-asset mining systems. It also develops and manages cybersecurity systems, provides blockchain platforms, invests in real estate, and engages in used car exports. Additionally, SBI offers healthcare services, participates in revitalization projects, mines digital assets, and is involved in e-sports and renewable energy initiatives. Established in 1999, the company was initially known as Softbank Investment Corporation before adopting its current name, SBI Holdings, Inc., in July 2005. Its headquarters are located in Tokyo, Japan.